Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07082569

Effect of Ventilation Mode in the Pupillary Light Reflex: A Crossover Study

The goal of this clinical trial is to explore whether different modes of mechanical ventilation affect pupillary constriction velocities in critically ill patients without brain injury. The study aims to determine whether the type of mechanical ventilation (volume control, pressure control, or pressure-regulated volume control) influences the maximum and mean constriction velocity measured by automated pupillometry. The trial also investigates whether changes in pupil dynamics reflect subtle alterations in brainstem-autonomic interaction induced by ventilation mode.

The comparison involves volume control, pressure control, and pressure-regulated volume control in a randomized crossover design to assess whether ventilation mode has a measurable effect on pupil response.

Eligible participants will be intubated ICU patients receiving assist control ventilation who are not yet ready for spontaneous breathing trials. Serial pupillometry measurements will be conducted while participants are ventilated with each mode for at least 15 minutes. Sedation and lighting conditions will remain consistent throughout the protocol. Participants with acute or chronic neurologic conditions or ventilator dyssynchrony will be excluded.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

!st ICU dpt., Evangelismos Hospital

Athens, 10676, Greece

About this study

This is a prospective, randomized, crossover study designed to evaluate the effect of different modes of mechanical ventilation on pupillary constriction velocity in critically ill patients. Recent data suggest that even in the absence of direct pulmonary or neurologic injury, mechanical ventilation with positive pressure may impact brain function, possibly through vagal-brainstem-autonomic pathways. These effects may be subtle and difficult to detect with standard neurological examination but may be reflected in changes in the dynamic pupillary light reflex.

The pupillary light reflex (PLR), measured using automated infrared pupillometry, provides a quantitative, non-invasive assessment of brainstem and autonomic nervous system function. IThe investigators aim to determine whether the PLR, specifically, the mean and maximum constriction velocity, differs across three commonly used ventilation modes: Volume Control (VC), Pressure Control (PC), and Pressure-Regulated Volume Control (PRVC).

All included participants will be mechanically ventilated, sedated, and not yet candidates for spontaneous breathing trials. Exclusion criteria include any acute or chronic neurologic disorder or signs of ventilator dyssynchrony. Sedation regimens (e.g., propofol, remifentanil, dexmedetomidine) will be kept constant during the study, and ambient light will remain unchanged.

Each participant will undergo the three ventilation modes in a randomized order, with each mode applied for a minimum of 15 minutes to ensure washout before pupillometry measurements are performed. Physiological parameters such as respiratory rate, minute ventilation, FiO₂, heart rate, and mean arterial pressure will be recorded in parallel with pupil measurements. Blood gas analysis and full pupillometry data, including pupil size, constriction and dilation velocities, latency, and the Neurological Pupil Index (NPi), will also be collected.

The primary outcome is the difference in maximum pupillary constriction velocity between ventilation modes. Secondary outcomes include mean constriction velocity, NPi, and other pupillary metrics. Based on pilot data, a total of 36 participants are required to detect a significant difference in the primary outcome. Statistical analysis will include repeated measures ANOVA or the Friedman test, with post hoc Wilcoxon Signed-Rank testing as appropriate.

The findings of this study may provide support for the use of pupillometry as a tool to assess subtle CNS effects of mechanical ventilation and could support the theory of ventilation-brainstem interactions during mechanical ventilation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients (≥18 years old)
  • Receiving positive-pressure mechanical ventilation
  • Under light or no sedation (e.g., RASS score between -2 and 0)
  • Clinically assessed by the treating physician as not yet ready for weaning from mechanical ventilation
  • Hemodynamically stable at the time of measurement
  • Presence of an arterial catheter in place for blood gas analysis
  • Written informed consent obtained from the patient's legal representative Exclusion Criteria
  • Acute or chronic neurological disease affecting brainstem function or pupillary responses
  • Dyssynchrony with the ventilator or need for high ventilatory support adjustments
  • Facial injuries, edema, or conditions precluding accurate pupillometry
  • Use of neuromuscular blocking agents within the prior 6 hours
  • Severe metabolic or acid-base imbalances that may influence autonomic regulation
  • Concurrent participation in another interventional study that could affect neurological or autonomic outcomes

Treatment and study plan

Volume Control Ventilation

Other

Standard mode of mechanical ventilation delivering a preset tidal volume. Commonly used in ICU patients requiring controlled ventilation.

Pressure Control Ventilation

Other

Pressure-targeted ventilation mode that delivers breaths at a fixed pressure. Commonly used in critically ill patients.

Pressure-Regulated Volume Control (PRVC)

Other

Hybrid ventilation mode that automatically adjusts inspiratory pressure to achieve a preset tidal volume.

Primary outcomes

  1. Maximum Pupillary Constriction Velocity

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Change in maximum pupillary constriction velocity (mm/s) in response to standardized light stimulus, as measured by the NPi-200 pupillometer, under three modes of mechanical ventilation: Volume Control (VC), Pressure Control (PC), and Pressure-Regulated Volume Control (PRVC).

Secondary outcomes

  1. Neurological Pupil Index (NPi)

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Change in NPi value recorded under each ventilation mode, reflecting pupillary reactivity and brainstem function.

  2. Constriction Latency

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Change in latency to onset of pupil constriction (seconds), measured using the NPi-200.

  3. Dilation Velocity

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Change in maximum dilation velocity (mm/s) following light stimulus, measured with the NPi-200.

  4. Maximum Pupil Diameter

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Change in maximum pupil diameter (mm) measured before light stimulation under each ventilation mode.

  5. Minimum Pupil Diameter

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Change in minimum pupil diameter (mm) recorded after light stimulation.

  6. Percent Constriction

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Percent change in pupil diameter from baseline in response to light stimulus.

Other outcomes

  1. Exploratory Outcome Measure - Heart Rate Variability (HRV)

    Time frame: Time interval between 15-30 minutes after the initiation of each ventilation mode (VC, PC, PRVC)

    HRV derived from ECG to explore autonomic nervous system modulation across ventilation modes (optional, if data acquisition becomes feasible).

  2. Systolic Blood Pressure (mmHg)

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Systolic blood pressure will be recorded during each ventilation mode to assess cardiovascular stability.

  3. Diastolic Blood Pressure (mmHg)

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Diastolic blood pressure will be recorded during each ventilation mode to assess cardiovascular stability.

  4. Mean Arterial Pressure (mmHg)

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Mean arterial pressure (MAP) will be recorded to evaluate overall hemodynamic stability.

  5. Heart Rate (beats per minute)

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Heart rate will be recorded to evaluate cardiovascular stability.

  6. Arterial Partial Pressure of Oxygen, PaO₂ (mmHg)

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    PaO₂ will be measured via arterial blood gas to assess oxygenation.

  7. Arterial Partial Pressure of Carbon Dioxide, PaCO₂ (mmHg)

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    PaCO₂ will be measured via arterial blood gas to assess ventilation efficiency.

  8. Tidal Volume (mL)

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Tidal volume will be recorded to ensure ventilator setting consistency.

  9. Respiratory Rate (breaths per minute)

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Respiratory rate will be recorded to monitor respiratory drive and ventilation stability.

  10. Minute ventilation (L/min)

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Minute ventilation will be recorded to assess ventilatory effectiveness and ensure consistency across modes.

  11. Ambient Illumination (lux)

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

    Ambient light intensity will be recorded to confirm consistent lighting conditions for pupillometry.

Study contacts

Contact information is provided by the study sponsor or research team.

Charikleia S. Vrettou, MD, PhD

CONTACT

[email protected]

+302132105621 ext. 5621

Sponsors and collaborators

Lead sponsor

Evangelismos Hospital

Other

Registry information

Acronym: EYE-BREATH

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Jul 24, 2025
Registry last updated
Jul 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.